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809-4 Pressure, Velocity, and Pulse Wave Propagation 
Proximal and Distal to a Modeled Adequately Repaired 
Coarctation of the Aorta 
Monica T. Youno, Xiaokui Li, Sebastian "1. Schindara, George D. Giraud, Huifang Wang, 
Grant H. Burch, Laura M. Nugent, Adrienne L. Binder, Muhammed Ashraf, David J. 
Sahn, Oregon Health & Science Universi~ Portland, Oregon. 
Background: A common chronic saquellae of aortic coarctation (CoA) is stiffening of the 
proximal aorta segment. Even after the coarctation is treated by balloon angioplasty or 
surgery, the difference in stiffness between proximal and distal segments remains. We 
studied velocity and pressure changes associated with these aortic alterations in the 
absence of obstruction in an in vitro model, Methods: Fresh dissected normal descend- 
ing aortas from 2 pigs were studied (30cm length, 1.1-1.3 cm diameters). The proximal 
aorta was heated to stiffen it. Each aorta was connected to a pulsatile flow system with a 
resistance section. Two different heart rates (HR) 50 and 90 beats/min at 8 different 
stroke volumes (20-60 ml) were studied. An ATL ultrasound scanner was used to acquire 
Doppler velocity from proximal to distal segments, and IVUS imaging and high fidelity 
pressure measurements were performed. Using the pressure and dimension measure- 
ments, the mean stiffness index of the aortas were calculated as ~ = LN [(SP / DP)/(SD - 
DD)], mean ~prox = 5.6, mean ~distal = 4.6. Results: Peak to peak pressure gradients 
were 2-9 mmHg at HR 50 and 3-18 mmHg at HR 90. Velocities rose from 0.62 ± 0.18 m/ 
sac proximal to 2.49 ± 0.72 m/sac at HR 60, and from 0.95 ± 0.17 m/sac proximal to 3.54 
± 0.63 m/sec distal at HR 90. Conclusions: The proximal stiffness of the aorta resulting 
from coarctation can affect pressure and blood flow velocity even after alleviation of the 
obstruction. 
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809-5 Does Subaortic Membrane Position Influence Mitrel 
Valve Function? 
James J. Paul. L. LuAnn Minich, Richard V. Williams, Linda M. Lambert, John A. 
Hawkins, Uoyd Y. Tani, Primary Children's Medical Center, Salt Lake Ci~ Utah. 
Isolated discrete subaortic stenosis (SAS) can cause left ventricular outflow tract (LVOT) 
obstruction and aortic regurgitation (AR). The membrane may also extend to the mitral 
valve, resulting in mitral regurgitation (MR). The purpose of this study was to determine 
the effect of subaortic membrane position on mitral valve function. Patients with isolated 
SAS who had undergone membranous resection were identified. Using the preop echo, 
the distance between the subaortic membrane on the ventdcular saptum to the hinge 
point of the right coronary cusp at the aortic annulus was measured and indexed by divid- 
ing by BSA °'5. LV shortening fraction, LVOT gradient, and presence of MR or AR were 
recorded. Trace MR was considered physiologic. All 21 patients (8.8+5.4 yr) who mat 
inclusion critada had normal shortening fractions (45+4%), and 11 had MR. Age, BSA °'s, 
LVOT gradient, and incidence of AR were similar in patients with and without MR. Com- 
pared to patients without MR, the indexed distance between the membrane and aortic 
valve was greater in patients with MR (see table, * = p<0.0003). An indexed distance of 8 
mm/m had a + predictive value of 92% and a - predictive value of 90% for the presence 
of MR. Thus, the distance between the subaortic membrane and aorta is predictive of 
MR. We speculate that the subaortic membrane tethers the anterior leaflet of the mitral 
valve, altering coaptation. Further study may determine if surgical resection of the mem- 
brane results in resolution of MR. 
Group (n=21) LVOT gradient (mmHg) AR Indexed Distance (ram/m) 
-MR (n=10) 63±23 6/10 5.8±1.8 
+MR (n=11) 49¢11 10/11 11.4±1.8* 
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820-I Development of a New Intravascular Stent (Genesis 
Stant) for Use in Infants and Chlldren Wlth Congenital 
Heart Disease 
Thomas J. Forbes, Edwin Roddguez-Cruz, Paul Webster, Zahid Amin, Lee Benson, 
Thomas Fagan, William Hellenbrand, Larry Latson, Phillip Moore, Julia Vincent, Charles 
Mullins, Children's Hospital of Michigan, Detroit, Michigan. 
Background. Use of intravascular stants that can be expanded to adult size is limited in 
infants and small children due to the large sheath size required for delivery. Purpose. The 
balloon expandable Genesis stant (GS), with sigma hinges, was developed for improved 
tractability and increased crimpabitity, thereby allowing it to be delivered through smaller 
sheaths. The GS was modified so that it could be expanded from 5-20 mm in diameter. 
Methods. In vitro and animal testing of the GS was performed to test pre-dalivary tractabil- 
ity, radial strength, and foreshortening characteristics in compedson to the Palmaz (P308) 
series. Seven swine underwent catheterization for placement of 30 GS in pulmonary and 
systemic arteries. Five swine ware sacdficad eady and 2 survivors underwent recathatsr- 
ization 8 weeks later for re-expansion of the GS to maximal size. Cinaangiography and 
intravascular ultrasound (IVUS) were performed following final expansion in the survivors. 
All stsnts ware explantad for further analysis. Results. The GS, loaded on an 8 mm balloon, 
was easily advanced through a 6 Fr sheath. A 7 Fr sheath was required for delivery of the 
GS on a 12 mm balloon. The P308 required an 8 Fr sheath for delivery. Radial strength 
was comparable between the GS and P308 at all diameters. In the acute animal study, a 
total of 22 stents were successfully placed by 9 physicians in pulmonary and systemic 
arteries. All stents, up to 12 mm in diameter, were successfully deployed through 7 Fr 
sheaths. In the survivors, all 8 stents were successfully expanded to 18-20 mm in diameter. 
IVUS and post explantation pathologic evaluation noted uniform expansion of the stents 
without evidence of fractures. Foreshortening of the GS was considerably less in comped- 
son to the P308 series (25.7 vs 44%). Conclusion. The new GS can be expanded to adult 
size and be delivered through smaller sheaths. It has supedor tractability and foreshorten- 
ing characteristics, and comparable radial strength in comparison to the P308 sedes. This 
study suggests the GS will make intravascular stent delivery technically easier and safer in 
infants, small children, and adults with vascular obstructions. 
11:15 a.m. 
820-2 Balloon Angioplasty and Stant Placement Through the  
Side of a Previously Placed Intravasculer Stant:  A New 
Option for the Interverd ional lat  
Jennifer M. Rutledae, Ronald G. Gdfka, Laura L. Bryant, Charles E. Mullins, Julia A. 
Vincent, Texas Children's Hospital, Houston, Texas, Texas Heart Institute, Houston, 
Texas. 
Background: Use of intravascular stents for relief of vascular stenosas in patients with 
congenital heart defects (CHD) may require that stents be positioned across the origin of 
side branch (SB) vessels. If a SB vessel is also stanotic or its origin compromised by ini- 
tial stent placement, dilation and/or stenting of the SB vessel has not been possible with 
currently available stents due to their closed-cell design. We report a sedas of successful 
balloon angioplasty and stenting of SB vessels through the side of a previously placed 
IntraStant TM DoublaStrut TM LD (IS-LD) stant in an animal model. 
Methods end Results: Six juvenile pigs (10-12 wk, mean 19.6 kg) underwent initial cath- 
eterization for placement of IS-LD stents in the aortic arch overlapping the left subclavian 
artery (n=3) or in the abdominal aorta overlapping the anterior mesantedc artery (n=3). A 
second cathetadzation was performed on all pigs after 8 wks (mean 45.7 kg) and original 
stants were redilated to accommodate somatic growth of the animal. After redilation, a 
guidewire and Glide~ catheter were maneuvered through side cells of each original stant 
into the SB vessel. The side cell was then dilated with a 7 mm balloon dilation catheter. A 
16 mm IS-LD stant mounted on a 10 mm balloon was then passed over a wire, through 
the side cell of the original stent and into the proximal SB vessel. In one case a 10Fr long 
sheath was advanced through the dilated side cell of the original stent prior to stent 
deployment. Follow-up angiography and intravascular ultrasound imaging confirmed 
excellent position of the SB stents with no evidence of compromised blood flow to the 
original or SB vessels and no significant distortion of the originally placed stents. 
Conclusion: The open-call design of the IS-LD stant allows access to SB vessels that 
arise off previously stented vessels. Balloon angioplasty and stenting of SB vessels can 
be accomplished through'the sides of these stents. Although there have been no reports 
of this procedure being performed in humans, this stent may provide an additional option 
for management of vascular stenoses in patients with CHD, especially those with periph- 
eral pulmonary artery stenosis or stenoses involving the aortic arch. 
